StockData
Charlie's Holdings, Inc. logo

Charlie's Holdings, Inc. (CHUC) stock

CHUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 3/30
$0.11+0.01 (+13.30%)

Close on Oct 19, 2026Market cap $31.05MP/E –Yield –

Charlie's Holdings, Inc. grew revenue 310.5% to $24.67M over the twelve months to Jun 30, 2026. Free cash flow was -$5.80M. At the latest close the market valued the company at $31.05M.

Revenue
$24.67M
+310.5% vs. a year earlier
Operating income
-$2.67M
TTM Q2 2026
Free cash flow
-$5.80M
FY2025
EPS, diluted
-$0.01
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$31.05M
P/E ratio
–
Price to sales
1.26
Price to book
9.90
Dividend yield
–
Free cash flow yield
-18.68%

Fundamentals

Revenue
$24.67M
Net income
-$1.96M
EPS, diluted
-$0.01
Free cash flow
-$5.80M
Book value per share
$0.01
Diluted shares
274M

Trading

Previous close
$0.10
Open
$0.10
Day's range
$0.09 – $0.12
Volume
47,683
Average volume (20 days)
78,716

Market cap history

Month-end market cap since 2013, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodCHUCS&P 500DifferenceCHUC per yearS&P 500 per year
1 month-33.4%+0.6%−34.0 pts
3 months-36.6%+3.4%−39.9 pts
Year to date-62.7%+13.3%−76.0 pts
1 year-57.8%+16.6%−74.4 pts
3 years+32.5%+86.4%−53.9 pts+9.8%+23.1%
5 years-23.4%+81.9%−105.3 pts-5.2%+12.7%
10 years-99.1%+318.9%−417.9 pts-37.5%+15.4%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$24.67M+310.5% YoY

Gross profit

$6.76M+233.5% YoY

Operating income

-$2.67M

Net income

-$1.96M-222.5% YoY

EPS, diluted

-$0.01

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Charlie's filed with the SEC as exhibits to Form 8-K or 6-K

About Charlie's

Medicinal Chemicals & Botanical Products

Charlie’s Holdings, Inc. formulates, markets, and distributes alternative alkaloid non-nicotine vapor products, electronic nicotine delivery systems, and non-combustible e-liquids. Its products include synthetic nicotine and tobacco-derived disposable devices under the Pacha and PACHAMAMA brands, refillable e-liquids, nicotine salt formulations, and zero-nicotine Metatine alkaloid disposables under the SBX line. The company also develops product access and compliance technologies, integrating Bluetooth-enabled age-verification systems into devices. It does not sell directly to consumers online, distributing products instead through specialty retailers, convenience stores, liquor stores, gas stations, direct sales, and wholesale distributors.

Company profile, executives and history

Charlie's stock: common questions

What is Charlie's's stock price?

CHUC closed at $0.11 on Oct 19, 2026, up 13.30% on the day.

What is Charlie's's market cap?

Charlie's was worth $31.05M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is CHUC's P/E ratio?

Charlie's lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.01), so it has no meaningful P/E ratio.

How much revenue does Charlie's make?

Charlie's reported revenue of $24.67M for the twelve months to Jun 30, 2026, up 310.5% from a year earlier.

Does Charlie's pay a dividend?

No. Charlie's has not paid a cash dividend over the last twelve months.

How has CHUC stock performed over the past year?

Including dividends, CHUC returned -57.8% over the past year, against +16.6% for the S&P 500.

Who are Charlie's's competitors?

Companies most similar to Charlie's by business, industry and size include CYAN, BON, SNYRQ, LEEEF, CWLXF.

See a number that looks wrong?